Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Aehr Test Systems’s stock clocked out at $21.81, up 1.58% from its previous closing price of $21.47. In other words, the price has increased by $1.58 from its previous closing price. On the day, 0.57 million shares were traded. AEHR stock price reached its highest trading level at $22.49 during the session, while it also had its lowest trading level at $21.48.
Ratios:
To gain a deeper understanding of AEHR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.54 and its Current Ratio is at 7.06. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on December 17, 2025, initiated with a Buy rating and assigned the stock a target price of $29. On July 17, 2024, Craig Hallum Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $12 to $25. Craig Hallum Downgraded its Buy to Hold on March 26, 2024, while the target price for the stock was maintained at $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 05 ’25 when SLAYEN HOWARD T sold 6,000 shares for $25.73 per share. The transaction valued at 154,357 led to the insider holds 218,328 shares of the business.
SLAYEN HOWARD T bought 6,000 shares of AEHR for $150,840 on Nov 05 ’25. On Oct 09 ’25, another insider, DANESH FARIBA, who serves as the Director of the company, sold 9,000 shares for $24.79 each. As a result, the insider received 223,101 and left with 16,643 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEHR now has a Market Capitalization of 654443712 and an Enterprise Value of 642350720. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.52 while its Price-to-Book (P/B) ratio in mrq is 5.34. Its current Enterprise Value per Revenue stands at 11.305 whereas that against EBITDA is -114.481.
Stock Price History:
The Beta on a monthly basis for AEHR is 2.34, which has changed by 0.5523132 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, AEHR has reached a high of $34.35, while it has fallen to a 52-week low of $6.27. The 50-Day Moving Average of the stock is -8.58%, while the 200-Day Moving Average is calculated to be 23.80%.
Shares Statistics:
It appears that AEHR traded 1.32M shares on average per day over the past three months and 566330 shares per day over the past ten days. A total of 29.97M shares are outstanding, with a floating share count of 27.85M. Insiders hold about 7.18% of the company’s shares, while institutions hold 68.65% stake in the company. Shares short for AEHR as of 1764288000 were 5079433 with a Short Ratio of 3.85, compared to 1761868800 on 4895591. Therefore, it implies a Short% of Shares Outstanding of 5079433 and a Short% of Float of 17.930001.
Earnings Estimates
The stock of Aehr Test Systems (AEHR) is currently being evaluated by 3.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.02, with high estimates of $0.04 and low estimates of $0.0.
Analysts are recommending an EPS of between $0.12 and $0.01 for the fiscal current year, implying an average EPS of $0.06. EPS for the following year is $0.26, with 3.0 analysts recommending between $0.46 and $0.13.
Revenue Estimates
In. The current quarter, 4 analysts expect revenue to total $11.58M. It ranges from a high estimate of $12.1M to a low estimate of $11.05M. As of. The current estimate, Aehr Test Systems’s year-ago sales were $13.45MFor the next quarter, 4 analysts are estimating revenue of $16.24M. There is a high estimate of $17.9M for the next quarter, whereas the lowest estimate is $12.4M.
A total of 4 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $63.87M, while the lowest revenue estimate was $49.5M, resulting in an average revenue estimate of $59.28M. In the same quarter a year ago, actual revenue was $58.97MBased on 4 analysts’ estimates, the company’s revenue will be $80.03M in the next fiscal year. The high estimate is $89.1M and the low estimate is $68.7M.
